Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme

被引:0
作者
Nalee Kim
Joongyo Lee
Do-Hyun Nam
Jung-Il Lee
Ho Jun Seol
Doo-Sik Kong
Jung Won Choi
Kyuha Chong
Won Jae Lee
Jong Hee Chang
Seok-Gu Kang
Ju Hyung Moon
Jaeho Cho
Do Hoon Lim
Hong In Yoon
机构
[1] Sungkyunkwan University School of Medicine,Department of Radiation Oncology, Samsung Medical Center
[2] Yonsei University College of Medicine,Department of Radiation Oncology, Yonsei Cancer Center, Severance Hospital, Yonsei University Health System
[3] Sungkyunkwan University School of Medicine,Department of Neurosurgery, Brain Tumor Center, Samsung Medical Center
[4] Yonsei University College of Medicine,Department of Neurosurgery, Severance Hospital, Yonsei University Health System
[5] Yonsei University College of Medicine,Brain Tumor Center, Severance Hospital, Yonsei University Health System
[6] Yonsei University College of Medicine,Department of Radiation Oncology, Heavy Ion Therapy Research Institute, Yonsei Cancer Center, Yonsei University Health System
来源
Journal of Neuro-Oncology | 2023年 / 165卷
关键词
Glioblastoma multiforme; Radiotherapy; Boost;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:261 / 268
页数:7
相关论文
共 184 条
[1]  
Stupp R(2005)Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 987-996
[2]  
Mason WP(2013)IMRT or 3D-CRT in glioblastoma? A dosimetric criterion for patient selection Technol Cancer Res Treat 12 411-420
[3]  
van den Bent MJ(2007)Intensity modulated radiation therapy versus three-dimensional conformal radiation therapy for the treatment of high grade glioma: a dosimetric comparison J Appl Clin Med Phys 8 47-60
[4]  
Weller M(2010)Intensity-modulated radiation therapy in newly diagnosed glioblastoma: a systematic review on clinical and technical issues Radiother Oncol 97 361-369
[5]  
Fisher B(2016)Radiation therapy for glioblastoma: executive summary of an American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline Pract Radiat Oncol 6 217-225
[6]  
Taphoorn MJ(2023)ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma Radiother Oncol 184 35-42
[7]  
Belanger K(2016)ESTRO-ACROP guideline “target delineation of glioblastomas” Radiother Oncol 118 945-952
[8]  
Brandes AA(2015)Simultaneous integrated vs. sequential boost in VMAT radiotherapy of high-grade gliomas Strahlenther Onkol 191 264-270
[9]  
Marosi C(2013)Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases: a planning study on treatment concepts Int J Radiat Oncol Biol Phys 85 51-2768
[10]  
Bogdahn U(2019)Clinical predictors of radiation-induced lymphopenia in patients receiving chemoradiation for glioblastoma: clinical usefulness of intensity-modulated radiotherapy in the immuno-oncology era Radiat Oncol 14 2759-103